Spectros has received validation for its core white LED patent during reexamination by the US Patent Office, and it will be reissued next year, the company said. After reexamining US Patent No. 6,711,426, the Patent Office affirmed that the company’s use of white LEDs in medical spectroscopy is unique and protectable, and that certain other applications in biomedical and industrial spectroscopy devices also fall under its patent. “This is a broad affirmation of our dominant I.P. in the white LED and broadband spectroscopy area,” CEO David Benaron said. “This will serve as the basis for our expansion into lab-on-chip devices, color sensors, spectrometers, fluorimeters and white LED pulse and tissue oximeters.” The company holds one of the earliest white LED patents in the US, and the first for use in medical and industrial spectroscopy, it said. With its affiliates, the company has over 80 patents issued, licensed or filed worldwide for molecular sensing, detection and imaging. Spectros markets and licenses advanced molecular sensing and imaging devices that can shed light on ischemia and cancer, as well as molecular diagnostic tools for breast and prostate cancer. For more information, visit: www.spectros.com